2. Epilepsy is defined as a brain
disorder characterized by an
enduring predisposition to
generate epileptic seizures
and by the neurobiologic,
cognitive, psychological, and
social consequences of this
condition.
3. Approach Considerations
The goal of treatment in patients with epileptic
seizures is to achieve a seizure-free status without
adverse effects
Monotherapy is desirable because it decreases the
likelihood of adverse effects and avoids drug
interactions.
People with seizures experience psychosocial
adjustments after their diagnosis; therefore, social
and/or vocational rehabilitation may be needed
4. Classification of Seizures
Focal seizures
(Can be further described as having motor, sensory,
autonomic, cognitive, or other features)
Generalized seizures
Absence
Typical
Atypical
Tonic clonic
Clonic
Tonic
Atonic
Myoclonic
May be focal, generalized, or unclear
Epileptic spasms
5. Anticonvulsant Therapy
Anticonvulsants can be divided based on their
mechanisms.
Blockers of repetitive activation of the sodium
channel: Phenytoin, carbamazepine,
oxcarbazepine, lamotrigine, topiramate
Enhancers of slow inactivation of the sodium
channel: Lacosamide, rufinamide
Gamma-aminobutyric acid (GABA)–A receptor
enhancers: Phenobarbital
N -methyl-D-aspartic acid (NMDA) receptor
blockers: Felbamate
8. Adverse Effects of Commonly Used
Antiepileptic Drugs
Drug Principal use Adverse effects
Valproic acid Tonic-clonic
Absence
Atypical
absence
Myoclonic
Focal-onset
Atonic
Ataxia
Sedation
Tremor
Hepatotoxicity
Thrombocytopenia
Gastrointestinal irritation
Weight gain
Transient alopecia
Hyperammonemia
9. Adverse Effects of Commonly Used
Antiepileptic Drugs
Drug Principal use Adverse effects
Carbamazepine UsesTonic-clonic
Focal-onset
Ataxia
Dizziness
Diplopia
Vertigo
Stevens johnson syndrome
Aplastic anemia
Leukopenia
Gastrointestinal irritation
Hepatotoxicity
Hyponatremia
10. Adverse Effects of Commonly Used
Antiepileptic Drugs
Drug Principal use Adverse effects
Levetiracetam Focal-onset
GTCS
Sedation
Fatigue
Incoordination
Mood changes
Anemia
Leukopenia
11. Adverse Effects of Commonly Used
Antiepileptic Drugs
Drug Principal use Adverse effects
Oxcarbazepine Focal-onset
Tonic-clonic
Fatigue
Ataxia
Dizziness
Diplopia
Vertigo
Headache
Aplastic anemia
Leukopenia
Gastrointestinal irritation
Hepatotoxicity
Hyponatremia
Hypersensitivity
13. Surgery for drug-resistant epilepsy
Although surgery for drug-resistant epilepsy is
often considered a last resort, results of a
multicenter trial suggested that early surgery may
be helpful in some patients with newly intractable
and disabling temporal lobe epilepsy
14. Anticonvulsants in Specific Patient
Populations
Women on contraceptive agents:
Anticonvulsants induce hepatic enzymes, such as
carbamazepine, phenytoin,lamotrigine, topiramate,
and oxcarbazepine leading to contraceptive failure
Some obstetricians use a high-dose estrogen-
progesterone contraceptive to counteract this
effect
An alternative and possibly preferable approach is
to use a second method of contraception
15. Women of childbearing age and pregnant
women
Woman of childbearing age should take folic acid,
at least 0.4 mg per day
During pregnancy, women should take the
medication that best controls their epilepsy
Switching medications during pregnancy is not
recommended, because of the risk of losing seizure
control and because it exposes the fetus to
polypharmacy
16. Women of childbearing age and pregnant
women
Data from multiple studies show an exponential risk
of birth defects as anticonvulsants are added in
polytherapy.
Frequent drug serum levels should be obtained
because of the many physiologic changes that take
place during pregnancy
In particular, decreased serum concentration of
lamotrigine in the third trimester is well documented,
and the dose needs to be adjusted after delivery
17. Patients with hepatic and renal insufficiency
Gabapentin, pregabalin, levetiracetam, and
lacosamide are excreted mostly by means of renal
clearance, and their doses can be adjusted for renal
insufficiency. These agents are useful in patients
with hepatic failure
Among all anticonvulsants, phenytoin,
carbamazepine, valproic acid, and felbamate have
been associated with acute hepatic injury.
18.
19. Risk of seizure recurrence
Several seizure types (eg, worse if tonic or atonic
seizures are present)
High number and frequency of seizures
Long duration of epilepsy before the seizures
were controlled
20. Discontinuing Anticonvulsant Agents
The following patient profile yields the greatest
chance of remaining seizure free after drug
withdrawal:
1. complete medical control of seizures for 1–
5 years
2. single seizure type, either focal or
generalized
3. normal neurologic examination, including
intelligence
4. normal EEG.
21. Discontinuing Anticonvulsant Agents
The appropriate seizure-free interval is unknown
and undoubtedly varies for different forms of
epilepsy
It seems reasonable to attempt withdrawal of
therapy after 2 years in a patient who meets all of
the above criteria, is motivated to discontinue the
medication, and clearly understands the potential
risks and benefits
In most cases it is preferable to reduce the dose
of the drug gradually over 2–3 months
22. Activity Modification and Restrictions
The major problem for patients with seizures is the
unpredictability of the next seizure. Clinicians should
discuss the following types of seizure precautions
with patients who have epileptic seizures or other
spells of sudden-onset seizures:
Driving
Ascending heights
Working with fire or cooking
Using power tools or other dangerous equipment
Taking unsupervised baths
Swimming